6 ML arsenic trioxide 2 MG/ML Injection — RxCUI 1992545
RxNorm drug concept · Semantic clinical drug
RxCUI 1992545
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1992545
Official name6 ML arsenic trioxide 2 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asarsenic trioxide 12 MG per 6 ML Injection; arsenic trioxide 12 MG in 6 ML Injection; arsenic trioxide 2 MG/ML per 6 ML Injection
FDA products mapped18
Package NDCs mapped21
Reported Medicaid activity (SDUD)551 prescriptions · 14 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Arsenic Trioxide Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats acute promyelocytic leukemia (APL), a type of blood cancer with a specific genetic marker. It is used for newly diagnosed low-risk APL along with tretinoin, and for APL t...
- It is given through an IV, usually over about 2 hours, by your healthcare team. You will have frequent blood tests and heart tracings to keep you safe. Your team will set the exact...
- Tell your team immediately about fever, trouble breathing, rapid weight gain, swelling, or low blood pressure. Also report fainting, a racing or irregular heartbeat, confusion, sei...
- What symptoms should I report right away?
🕸️ Concept Web — How 6 ML arsenic trioxide 2 MG/ML Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
6 ML arsenic trioxide 2 MG/ML Injection
RxCUI 1992545 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Arsenic trioxide
18330IN
-
Arsenic trioxide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Trisenox
829877BN
-
Trisenox
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Arsenic trioxide Injection
1804033SCDF -
Arsenic trioxide Injectable Product
1158265SCDG -
Arsenic trioxide Injection [Trisenox]
1804036SBDF -
Trisenox Injectable Product
1185002SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Arsenic trioxide Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Arsenic trioxide 2 MG/ML
1992544SCDC -
6 ML arsenic trioxide 2 MG/ML Injection [Trisenox]
1992547SBD -
Arsenic trioxide 2 MG/ML [Trisenox]
1992546SBDC
-
Arsenic trioxide 2 MG/ML
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Arsenic trioxide 2 MG/ML
SCDC · 1992544 -
Arsenic trioxide Injection
SCDF · 1804033 -
Arsenic trioxide Injectable Product
SCDG · 1158265
Brand-Name Concepts
-
6 ML arsenic trioxide 2 MG/ML Injection [Trisenox]
SBD · 1992547 -
Arsenic trioxide 2 MG/ML [Trisenox]
SBDC · 1992546 -
Arsenic trioxide Injection [Trisenox]
SBDF · 1804036 -
Trisenox Injectable Product
SBDG · 1185002 -
Trisenox
BN · 829877
📦 FDA Products & Package NDCs
18 products · 21 package NDCs
21 package NDCs map to RxCUI 1992545 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00781-3498-94 | 1 VIAL in 1 CARTON (0781-3498-94) / 6 mL in 1 VIAL | Arsenic Trioxide | Sandoz Inc | 2022-05-19 |
| 00781-3498-95 | 10 VIAL in 1 CARTON (0781-3498-95) / 6 mL in 1 VIAL (0781-3... | Arsenic Trioxide | Sandoz Inc | 2022-05-19 |
| 23155-0869-41 | 10 VIAL, SINGLE-DOSE in 1 CARTON (23155-869-41) / 10 mL in... | Arsenic Trioxide | Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc | 2023-06-23 |
| 23155-0870-41 | 10 VIAL, SINGLE-DOSE in 1 CARTON (23155-870-41) / 6 mL in 1... | Arsenic Trioxide | Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc | 2023-06-23 |
| 25021-0226-10 | 10 VIAL in 1 CARTON (25021-226-10) / 10 mL in 1 VIAL | Arsenic Trioxide | Sagent Pharmaceuticals | 2023-02-15 |
| 25021-0227-06 | 10 VIAL in 1 CARTON (25021-227-06) / 6 mL in 1 VIAL | Arsenic Trioxide | Sagent Pharmaceuticals | 2023-02-15 |
| 49315-0007-10 | 10 VIAL in 1 CARTON (49315-007-10) / 6 mL in 1 VIAL (49315-... | Arsenic trioxide | Zydus Lifesciences Limited | 2019-09-03 |
| 55150-0366-10 | 10 CARTON in 1 CARTON (55150-366-10) / 1 VIAL, SINGLE-DOSE... | ARSENIC TRIOXIDE | Eugia US LLC | 2021-10-15 |
| 63459-0601-06 | 10 VIAL, SINGLE-DOSE in 1 CARTON (63459-601-06) / 6 mL in 1... | Trisenox | Cephalon, LLC | 2017-12-22 |
| 68083-0462-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-462-10) / 6 mL in 1... | Arsenic Trioxide | Gland Pharma Limited | 2021-10-07 |
| 68083-0535-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (68083-535-10) / 10 mL in... | Arsenic Trioxide | Gland Pharma Limited | 2022-04-22 |
| 70121-1483-07 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70121-1483-7) / 10 mL in... | Arsenic Trioxide | Amneal Pharmaceuticals LLC | 2021-01-25 |
| 70121-1658-01 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70121-1658-1) / 6 mL in 1... | Arsenic Trioxide | Amneal Pharmaceuticals LLC | 2021-08-20 |
| 70710-1610-06 | 10 VIAL in 1 CARTON (70710-1610-6) / 6 mL in 1 VIAL (70710-... | Arsenic trioxide | Zydus Pharmaceuticals USA Inc. | 2019-09-03 |
| 70710-1896-06 | 10 VIAL in 1 CARTON (70710-1896-6) / 6 mL in 1 VIAL (70710-... | Arsenic trioxide | Zydus Pharmaceuticals USA Inc. | 2023-02-28 |
| 81607-0005-11 | 10 VIAL, SINGLE-DOSE in 1 CARTON (81607-005-11) / 10 mL in... | ARSENIC TRIOXIDE | Orbicular Pharmaceutical Technologies Private Limited | 2023-05-31 |
| 81607-0006-07 | 10 VIAL, SINGLE-DOSE in 1 CARTON (81607-006-07) / 6 mL in 1... | ARSENIC TRIOXIDE | Orbicular Pharmaceutical Technologies Private Limited | 2023-05-31 |
| 83090-0009-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83090-009-01) / 10 mL in 1... | ARSENIC TRIOXIDE | Sintetica US LLC | 2023-11-09 |
| 83090-0009-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (83090-009-10) / 10 mL in... | ARSENIC TRIOXIDE | Sintetica US LLC | 2023-11-09 |
| 83090-0010-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83090-010-01) / 6 mL in 1... | ARSENIC TRIOXIDE | Sintetica US LLC | 2023-11-09 |
| 83090-0010-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (83090-010-10) / 6 mL in 1... | ARSENIC TRIOXIDE | Sintetica US LLC | 2023-11-09 |
Observed labelers:
Sintetica US LLC (4) ·
Amneal Pharmaceuticals LLC (2) ·
Gland Pharma Limited (2) ·
Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Inc (2) ·
Orbicular Pharmaceutical Technologies Private Limited (2) ·
Sagent Pharmaceuticals (2)
· +5 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9017 | Arsenic trioxide injection | 11 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.